Monday 5 October

11.00–11.10Welcome to HIV Glasgow 2020
Andrew Phillips, London, UK

11.10–12.30HIV and Obesity

11.10–11:15Welcome and Introduction
Alexandra Calmy, Geneva, Switzerland

11.15–11:45Keynote Lecture
Andrew Carr, Sydney, Australia

11.45–11:53Fat distribution and density in people living with HIV with ≥5% weight gain
Giovanni Guaraldi, Modena, Italy

11.53–12:01Weight gain plateaus at 24-months follow-up for ART-experienced patients that
switched to dolutegravir in a Nigerian early adopter cohort
Jennifer Campbell, Boston, MA, USA,

and
Sulaimon Akanmu, Lagos, Nigeria

12.01–12:30Panel discussion and Q & A

12.30–12.45Break

12.45–13.30COVID-19: Where are We Now and What Next?

12.45–13.15Keynote Lecture
Karine Lacombe,Paris, France

13.15–13.30Q&A

13.30–13.45Break

13.45–15.00Industry Symposium

15.00–15.30Break

15.30–16.45COVID-19: Challenges and Lessons Learned. Country Perspectives

15.30–15.35Introduction

15.35–15.42South Korea
Presenter tbc

15.42–15.49Italy
Cristina Mussini, Modena, Italy

15.49–15.56Spain
Santiago Moreno, Madrid Spain

15.56–16.03USA
Daniel Kuritzkes, Boston, MA, USA

16.03–16.10Ivory Coast
Presenter tbc

16.10–16.17South Africa
Mary-Ann Davies, Cape Town, South Africa

16.17–16.24Brazil
Beatriz Grinsztejn, Rio de Janeiro, Brazil

16.24–16.45Panel Discussion and Q&A

16.45–17.00Break

17.00–18.15Ageing, Paediatrics and Cancer

17.00–17.15HIV and ageing
Eugenia Negredo, Barcelona, Spain

17.15–17.30What is new in HIV paediatrics?
Hermione Lyall, London, UK

17.30–17.45Cancer screening and treatment
Jean Philippe Spano, Paris, France

17.45–17.53The relationship between smoking, CD4, viral load and cancer risk in HIV-positive
adults (OIs)
Amanda Mocroft on behalf of RESPOND

17.53–18.15Q&A